Search by Drug Name or NDC
NDC 50804-0198-02 Motion Sickness 50 mg/1 Details
Motion Sickness 50 mg/1
Motion Sickness is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Geiss, Destin & Dunn Inc.. The primary component is DIMENHYDRINATE.
MedlinePlus Drug Summary
Dimenhydrinate is used to prevent and treat nausea, vomiting, and dizziness caused by motion sickness. Dimenhydrinate is in a class of medications called antihistamines. It works by preventing problems with body balance.
Related Packages: 50804-0198-02Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Dimenhydrinate
Product Information
| NDC | 50804-0198 |
|---|---|
| Product ID | 50804-198_893b3614-9cfa-4855-896a-76c0504a9899 |
| Associated GPIs | |
| GCN Sequence Number | 004720 |
| GCN Sequence Number Description | dimenhydrinate TABLET 50 MG ORAL |
| HIC3 | H6J |
| HIC3 Description | ANTIEMETIC/ANTIVERTIGO AGENTS |
| GCN | 18231 |
| HICL Sequence Number | 004603 |
| HICL Sequence Number Description | DIMENHYDRINATE |
| Brand/Generic | Generic |
| Proprietary Name | Motion Sickness |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Dimenhydrinate |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 50 |
| Active Ingredient Units | mg/1 |
| Substance Name | DIMENHYDRINATE |
| Labeler Name | Geiss, Destin & Dunn Inc. |
| Pharmaceutical Class | Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M009 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50804-0198-02 (50804019802)
| NDC Package Code | 50804-198-02 |
|---|---|
| Billing NDC | 50804019802 |
| Package | 2 BLISTER PACK in 1 CARTON (50804-198-02) / 6 TABLET in 1 BLISTER PACK |
| Marketing Start Date | 2020-04-07 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |